Michele Rhee is the Director of Strategic Initiatives of the National Brain Tumor Society. In this role, she manages strategic programs focused on achieving a mission by effecting change within different facets of the drug discovery and development landscape, including partnerships with academia, the private sector, and government. She is also Director of Strategic Initiatives for Costs of Care, a nonprofit that helps patients and their caregivers deflate their